CNS Pharmaceuticals, Inc. — Form D

CNS Pharmaceuticals, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-19. The offering totals $22.5M, of which $22.5M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2026-05-19
• Form: D
• Accession: 0001683168-26-004126
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $22.5M
• Amount sold: $22.5M
• Investors: 13
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-584551

Issuer

• Name: CNS Pharmaceuticals, Inc.
• CIK: 0001729427
• Entity type: Corporation
• Jurisdiction: NEVADA
• Address: 2100 WEST LOOP SOUTH SUITE 900, HOUSTON, TX, 77027
• Phone: 800-946-9185

Officers, directors & promoters (7)

More

• CIK 1729427 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search